Recent Developments in the Drug Treatment of Parkinson’s Disease
Abstract Parkinson’s disease (PD) is a common neurodegenerative disorder caused by a spread of misfolded α-synuclein and ascending neuronal degeneration…
Abstract Parkinson’s disease (PD) is a common neurodegenerative disorder caused by a spread of misfolded α-synuclein and ascending neuronal degeneration…
Abstract Background: Periodontitis is a chronic inflammatory disease characterized by dysbiotic biofilm formation, progressive destruction of periodontal tissues, and alveolar…
Abstract KITENIN (KAI1 C-terminal interacting tetraspanin) has emerged as a critical oncogenic mediator involved in tumor initiation, progression, metastasis, and…
Abstract Major Depressive Disorder (MDD) is a highly prevalent and disabling psychiatric disorder, representing a major global health burden across…
Abstract Neuropsychiatric disorders represent a significant global health burden. Despite decades of research, current treatments typically provide only symptomatic relief,…
Abstract Background: Cannabidiol (CBD) has emerged as a promising adjunctive therapy for drug-resistant epilepsy, yet clinical findings remain heterogeneous across…
Abstract Hemp (Cannabis sativa L.) is a multipurpose crop with significant industrial and therapeutic potential. This article reviews the various…
Abstract The consumption of cannabinoids is highly prevalent and has been associated with altered structural, functional, and metabolic brain integrity,…
Abstract Head and neck squamous cell carcinoma is one of the most common cancer types worldwide. The standard therapy for…
Abstract Casearia sylvestris Sw. (Salicaceae) is a South American medicinal plant traditionally used for the treatment of inflammatory conditions, pain,…